Elevance Health (ELV) Expected to Announce Quarterly Earnings on Thursday

Elevance Health (NYSE:ELV) will likely be releasing its earnings data before the market opens on Thursday, January 23rd. Analysts expect Elevance Health to post earnings of $3.80 per share and revenue of $44,633,169.71 billion for the quarter. Persons that wish to listen to the company’s earnings conference call can do so using this link.

Elevance Health Price Performance

NYSE ELV opened at $389.45 on Wednesday. The stock’s fifty day moving average price is $387.20 and its 200 day moving average price is $465.15. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.50 and a quick ratio of 1.50. The company has a market cap of $90.32 billion, a price-to-earnings ratio of 14.20, a PEG ratio of 1.09 and a beta of 0.84. Elevance Health has a 1 year low of $362.21 and a 1 year high of $567.26.

Analysts Set New Price Targets

Several equities analysts recently weighed in on ELV shares. Barclays cut their price target on shares of Elevance Health from $622.00 to $501.00 and set an “overweight” rating on the stock in a report on Tuesday, October 22nd. Argus lowered Elevance Health from a “buy” rating to a “hold” rating in a research report on Friday, October 18th. UBS Group cut their target price on shares of Elevance Health from $605.00 to $555.00 and set a “buy” rating for the company in a report on Friday, October 18th. Morgan Stanley decreased their target price on shares of Elevance Health from $643.00 to $551.00 and set an “overweight” rating for the company in a research note on Wednesday, October 23rd. Finally, TD Cowen dropped their price target on shares of Elevance Health from $589.00 to $484.00 and set a “buy” rating on the stock in a research report on Monday, October 21st. One analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, Elevance Health currently has a consensus rating of “Moderate Buy” and a consensus target price of $536.53.

About Elevance Health

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.